Sunlight Research will be offering a webinar entitled "How Are iPSCs Changing the Stem Cell Patent Landscape?" on October 6, 2010 from 12:00 - 12:50 PM (EST). Dr. Robin Chadwick of Schwegman, Lundberg & Woessner, P.A. will provide insight into the induced pluripotent stem cell (iPSC) patent activities of leading stem cell business and research institutions, illuminating potential commercialization obstacles and co-development opportunities. The webinar will provide answers to the following questions:
• What and how many iPSC patents have been issued?
• Who owns them?
• What obstacles to commercial development do these issued patents present to other iPSC researchers and developers?
• Are these patents easy to design around, or should they be licensed or acquired now before prices rise?
• How many pending patent applications cover iPSC technology?
• What are the key ones to watch as they move through the Patent Office?
The registration fee for the webinar is $147 (single viewer), $197 (2-5 viewers), or $447 (6-20 viewers). Those interested in registering for the webinar, can do so here.
Thankfully, new technological advances that have yielded genetically engineered stem cells and he use of umbilical cord stem cells will serve as potential nails in the coffin of the stem cell moral debate. And not only does the new technology save time and cost, but it could also prove quite lucrative in patent enforcement. Kudos all around.
http://www.generalpatent.com/media/videos/general-patent-gets-results-its-clients
Posted by: patent litigation | October 04, 2010 at 06:53 PM